
Yasuhiro Nakagiri
About Yasuhiro Nakagiri
Data last updated:
Yasuhiro Nakagiri is an Additional Director at Medreich Limited (since 2024), Director at Adcock Ingram Limited (since 2024) and Director at Adcock Ingram Pharma Private Limited (since 2024). The companies operate in Pharma and Business Services. The 3 current companies with reported revenue have a combined latest revenue of ₹2,248 Cr; the largest is Medreich Limited at ₹1,737 Cr (FY 2024). Earlier, Yasuhiro Nakagiri was a Managing Director at Astellas Pharma India Private Limited (2017–2020) and Director at Organisation Of Pharmaceutical Producers Of India (2017–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Additional Director | 09 May 2024 | 1973 | ₹1,737 Cr (FY 2024) | Active | |
| Director | 08 May 2024 | 2007 | ₹464 Cr (FY 2025) | Active | |
| Director | 08 May 2024 | 2021 | ₹47.27 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Managing Director | 29 Sep 2017 | 2008 | ₹68.97 Cr (FY 2025) | Active | |
| Director | 01 Apr 2017 | 1965 | ₹15.58 Cr (FY 2025) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Yasuhiro Nakagiri
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Yasuhiro Nakagiri
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Yasuhiro Nakagiri
Yasuhiro Nakagiri currently holds 3 directorships: Medreich Limited (Additional Director, since 09 May 2024, revenue ₹1,737 Cr (FY 2024)); Adcock Ingram Limited (Director, since 08 May 2024, revenue ₹464 Cr (FY 2025)); Adcock Ingram Pharma Private Limited (Director, since 08 May 2024, revenue ₹47.27 Cr (FY 2025)).
Yasuhiro Nakagiri was first appointed on 01 Apr 2017 as Director at Organisation Of Pharmaceutical Producers Of India. The most recent appointment on record is 09 May 2024 at Medreich Limited.
The 3 current companies of Yasuhiro Nakagiri that report revenue have a combined latest revenue of ₹2,248 Cr: Medreich Limited ₹1,737 Cr (FY 2024); Adcock Ingram Limited ₹464 Cr (FY 2025); Adcock Ingram Pharma Private Limited ₹47.27 Cr (FY 2025).
Yasuhiro Nakagiri held 2 earlier board appointments: Astellas Pharma India Private Limited (Managing Director, 29 Sep 2017 to 19 Jun 2020); Organisation Of Pharmaceutical Producers Of India (Director, 01 Apr 2017 to 31 Mar 2020).
The current boards of Yasuhiro Nakagiri's companies include Kenshi Murase (Medreich Limited), Misa Hirose (Medreich Limited), Pankaj Garg (Medreich Limited), Ramapuram Sreenivasulu Reddy (Medreich Limited), Ryoji Kikuchi (Medreich Limited), Tsutomu Yamada (Medreich Limited), among others.